Posts In: Gubba Pharma In E News

Sun Pharma, Lupin Recall Products In US Market, Says USFDA

November 24, 2021 Gubba Pharma In E News

Leading drugmakers Sun Pharma and Lupin are recalling different products in the US, the world’s largest market for medicines, for different reasons. As per the...

Continue Reading

AIMIL Pharma launches ayurveda-based beauty product

November 24, 2021 Gubba Pharma In E News

The Fragrance and Flavour Development Centre in Kannauj has come up with beauty products in association with the Delhi-based AIMIL Pharma in line with the...

Continue Reading

Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell remedy firm

November 24, 2021 Gubba Pharma In E News

Laurus mentioned it has signed an settlement to put money into Immunoadoptive Cell Therapy Private Limited (ImmunoACT), that is growing an indigenous CAR T-cell remedy...

Continue Reading

Here’s how Venus Remedies is striking ahead with cutting- edge tech

November 17, 2021 Gubba Pharma In E News

Venus Remedies is going from strength to strength with the adoption of bleeding-edge technology in its research, manufacturing, and communication infrastructure, striving to become a...

Continue Reading

J&J to spin off consumer products and focus on pharmaceuticals

November 17, 2021 Gubba Pharma In E News

Johnson & Johnson (JNJ.N) plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices...

Continue Reading

UK becomes first country to approve Merck’s anti-Covid pill molnupiravir

November 17, 2021 Gubba Pharma In E News

Britain approved the use of Merck’s antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency (MHRA)...

Continue Reading

Sun Pharma might finally have a prescription for the specialty dream

November 10, 2021 Gubba Pharma In E News

Sun Pharmaceutical Industries is increasingly showing signs that it has left behind the stuttering start to its journey to become a The drugmaker reported 6...

Continue Reading

Molnupiravir and Paxlovid: Two new oral drugs and the treatment of Covid-19

November 10, 2021 Gubba Pharma In E News

The UK drug regulator announced that it has approved the first oral antiviral for treatment of Covid-19. The drug, molnupiravir, has been developed by Merck...

Continue Reading

Cadila Healthcare gets Central govt order to supply 10 mn doses of ZyCoV-D

November 10, 2021 Gubba Pharma In E News

Cadila Healthcare (Zydus Cadila) on Monday said it has received an order to supply 10 million doses of ZyCoV-D, the world’s first Plasmid DNA vaccine,...

Continue Reading